TSHA
Taysha Gene Therapies, Inc. Common Stock
$4.15
-5.79%
-0.25
Notify me if price changes either direction
Buy TSHA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.2B
Enterprise value
919.6M
Trailing PE
2.5317461
Forward PE
-8.784236
PEG Ratio
-0.25317461
Enterprise to EBITDA
-8.409
Enterprise to revenue
94.092
Price to book MRQ
4.6997695
Price to sales TTM
119.63455
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
9.8M
EBITDA
-109353000
Diluted EPS TTM
-0.34
Total Cash (MRQ)
319.8M
Current ratio (MRQ)
12.227
Operating Cash Flow (TTM)
-93090000
TSHA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
